Bluejay Diagnostics
BJDX • NASDAQ
Bluejay Diagnostics is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Indranil Dey, with a market cap of $2.1M.
CEOIndranil Dey
Market Cap$2.1M
Medical - Devices
Healthcare
Employees16.0
Websitebluejaydx.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Bluejay Diagnostics
Date
Monday, March 30, 2026 (in 2 months)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q4 2025
Earnings History
Past 12 earnings reports for Bluejay Diagnostics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 7, 2025 | Q3 2025 | -$1.01 | — | - | — |  10-Q |
| Aug 7, 2025 | Q2 2025 | -$1.41 | — | - | — | 10-Q |
| May 13, 2025 | Q1 2025 | -$3.37 | — | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$23.19 | — | - | — | 10-K/A |
| Nov 7, 2024 | Q3 2024 | -$8.00 | — | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$256.00Est: -$36.00 | -611.1% | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$396.00Est: -$288.00 | -37.5% | - | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$712.00Est: -$272.00 | -161.8% | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$832.00 | — | - | — | — |
| Aug 16, 2023 | Q2 2023 | -$1,100.00Est: -$600.00 | -83.3% | -Est: $420.0K | -100.0% | 10-Q |
| May 10, 2023 | Q1 2023 | -$960.00Est: -$480.00 | -100.0% | -Est: $810.0K | -100.0% | — |
| Mar 20, 2023 | Q4 2022 | -$960.00Est: $320.00 | -400.0% | - | — | — |